An estimated 12% of Americans have been prescribed a GLP-1 medication, according to study background
In a large propensity-matched analysis presented by Orland et al., GLP-1RA initiation after stage IIII cancer diagnosis was associated with reduced metastatic progression across multiple malignancies
Therefore, it can be proposed that regardless of fever, patients with infection should be treated with glutathione
We anticipate that the search for more specific GST inhibitors will be the main goal of future research in this field
Conclusion Although topical glutathione shows promise for dermatological applications, further larger randomized controlled trials with long-term follow-up are necessary to evaluate its utility more comprehensively in improving hyperpigmentation, erythema, and reducing free-radical damage
The reality is a bit more nuanced